Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Ottawa knocked off Toronto Metropolitan University, an OUA finalist that counted former Wolves captain Liam Ross among its ...

(Tricuspid or pulmonary valve disease, by itself, is an infrequent cause of right-sided heart failure.) Stenosis of the mitral valve (the valve that lies between the left atrium and left ventricle), a ...

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Pitted against more established balloon-expandable Sapien 3 valves in TAVR for severe aortic stenosis, the Myval devices ...

Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

The U.S. Centers for Medicare & Medicaid Services (CMS) issued a draft coverage memo for transcatheter edge-to-edge repair for the tricuspid valve (T-TEER), which is a development that promises ...

A distinctive type of pulmonary valvular stenosis, termed "pulmonary valvular dysplasia," is described from six necropsies and 10 living children. The anatomic features of the stenotic pulmonary valve ...

ed.ac.uk To review the pathophysiology of fibrocalcific aortic stenosis, the myocardial response to pressure overload and current clinical guidelines concerning the timing of valve intervention. To ...

med.ulaval.ca To be aware of the prevalence, pathophysiology and outcomes of mixed aortic valve disease (MAVD), which refers to combined aortic stenosis and aortic regurgitation. To assess the ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...